| Primary |
| Drug Use For Unknown Indication |
25.6% |
| Hot Flush |
13.6% |
| Menopause |
12.4% |
| Hormone Replacement Therapy |
12.1% |
| Menopausal Symptoms |
9.3% |
| Product Used For Unknown Indication |
6.9% |
| Pain |
2.8% |
| Depression |
2.3% |
| Anxiety |
1.8% |
| Blood Pressure Management |
1.4% |
| Cardiac Disorder |
1.4% |
| Cerebrovascular Accident Prophylaxis |
1.4% |
| Herpes Virus Infection |
1.4% |
| Hypercholesterolaemia |
1.4% |
| Meniere's Disease |
1.4% |
| Nausea |
1.4% |
| Insomnia |
0.8% |
| Osteoporosis |
0.8% |
| Osteoporosis Postmenopausal |
0.8% |
| Unevaluable Event |
0.8% |
|
| Application Site Rash |
14.9% |
| Vaginal Haemorrhage |
12.7% |
| Product Quality Issue |
10.8% |
| Product Adhesion Issue |
10.6% |
| Hot Flush |
9.8% |
| No Adverse Event |
6.0% |
| Metrorrhagia |
5.1% |
| Rash |
4.2% |
| Night Sweats |
2.8% |
| Pharmaceutical Product Complaint |
2.6% |
| Pruritus |
2.6% |
| Application Site Erythema |
2.5% |
| Insomnia |
2.5% |
| Rash Pruritic |
2.3% |
| Drug Ineffective |
2.1% |
| Pain |
2.1% |
| Alopecia |
1.9% |
| Abdominal Distension |
1.5% |
| Application Site Irritation |
1.5% |
| Application Site Pruritus |
1.5% |
|
| Secondary |
| Hot Flush |
24.1% |
| Hormone Replacement Therapy |
22.6% |
| Menopause |
12.3% |
| Drug Use For Unknown Indication |
7.7% |
| Insomnia |
4.1% |
| Product Used For Unknown Indication |
4.1% |
| Depression |
3.6% |
| Menopausal Symptoms |
3.1% |
| Osteopenia |
2.6% |
| Dysmenorrhoea |
2.1% |
| Headache |
2.1% |
| Hormone Therapy |
2.1% |
| Autonomic Nervous System Imbalance |
1.5% |
| Fatigue |
1.5% |
| Migraine |
1.5% |
| Arthritis |
1.0% |
| Back Pain |
1.0% |
| Blood Pressure |
1.0% |
| Gastrooesophageal Reflux Disease |
1.0% |
| Night Sweats |
1.0% |
|
| Hot Flush |
12.7% |
| Product Adhesion Issue |
11.4% |
| Vaginal Haemorrhage |
8.9% |
| Breast Cancer |
7.6% |
| Paraesthesia |
7.6% |
| Product Quality Issue |
6.3% |
| Metrorrhagia |
5.1% |
| Tinnitus |
5.1% |
| Weight Decreased |
5.1% |
| Application Site Rash |
3.8% |
| Menstrual Disorder |
3.8% |
| Rash |
3.8% |
| Alopecia |
2.5% |
| Drug Ineffective |
2.5% |
| Hypersomnia |
2.5% |
| No Adverse Event |
2.5% |
| Palpitations |
2.5% |
| Poor Quality Sleep |
2.5% |
| Skin Irritation |
2.5% |
| Application Site Bleeding |
1.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
12.5% |
| Back Pain |
8.3% |
| Angiogram |
6.9% |
| Depression |
6.9% |
| Nuclear Magnetic Resonance Imaging |
6.9% |
| Blood Cholesterol Increased |
5.6% |
| Drug Use For Unknown Indication |
5.6% |
| Hormone Replacement Therapy |
5.6% |
| Rhinitis Allergic |
5.6% |
| Type 2 Diabetes Mellitus |
5.6% |
| Hypertension |
4.2% |
| Menopause |
4.2% |
| Convulsion |
2.8% |
| Diabetes Mellitus |
2.8% |
| Dyslipidaemia |
2.8% |
| Dyspepsia |
2.8% |
| Enzyme Supplementation |
2.8% |
| Fluid Retention |
2.8% |
| Gastric Disorder |
2.8% |
| Gastrooesophageal Reflux Disease |
2.8% |
|
| Vomiting |
15.8% |
| Nausea |
10.5% |
| Pancreatitis |
10.5% |
| Withdrawal Syndrome |
10.5% |
| Arthralgia |
5.3% |
| Depression |
5.3% |
| Drug Dose Omission |
5.3% |
| Heart Rate Increased |
5.3% |
| Injection Site Swelling |
5.3% |
| Pain In Extremity |
5.3% |
| Poor Quality Sleep |
5.3% |
| Pyrexia |
5.3% |
| Sleep Disorder |
5.3% |
| White Blood Cell Count Increased |
5.3% |
|
| Interacting |
| Hot Flush |
50.0% |
| Product Used For Unknown Indication |
50.0% |
|
|
